Φορτώνει......
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy
BACKGROUND: Minimal improvements in treatment or survival of patients with osteosarcoma have been achieved during the last three decades. Especially in the case of incomplete tumor resection, prognosis remains poor. Heavy ion radiotherapy (HIT) and modern anticancer drugs like histone deacetylase in...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Radiat Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504102/ https://ncbi.nlm.nih.gov/pubmed/26178881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0455-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|